There are general risk factors for patients with rheumatic disease developing interstitial lung disease, but there are also disease-specific risk factors depending on which rheumatic disease they have ...
Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...
If you often have a difficult time breathing or if you suffer from a dry and persistent cough, you may be suffering from a condition known as interstitial lung disease. A Hauʻula teen's passion for a ...
The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant non-small cell lung cancer (NSCLC), according to data from a trial led by ...
Protein tyrosine phosphatase non-receptor type 2 ( PTPN2 ) is a tyrosine phosphatase involved in T cell receptor signal ...
Background: Krebs von den Lungen-6 (KL-6), predominantly expressed by type II alveolar cells, is linked to the prognosis and severity of interstitial lung disease (ILD). This investigation sought to ...
Vitamin C may have the potential to protect people against lung disease caused by traffic-related air pollution, bushfires and dust storms, new research finds. After returning from what felt like the ...
Patients with inflammatory bowel disease (IBD) had a significantly higher risk for developing interstitial lung disease (ILD) compared with the general population and siblings who do not have the ...
Childhood interstitial lung disease (chILD) comprises a heterogeneous group of rare, chronic pulmonary disorders that affect the lung parenchyma. These conditions are characterised by complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback